A Democratic bill with 17 Democratic cosponsors · See all 18 cosponsors
Last activity — Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
The Drug Deal Disclosure Act requires the Department of Health and Human Services to release documents and communications regarding private drug pricing deals with manufacturers. These deals include agreements on reduced prices, direct-to-consumer sales, and import duty exemptions. The bill covers specific agreements announced by various pharmaceutical companies and any subsequent new agreements. Information must be made available in a centralized, searchable, and downloadable format. The Secretary is prohibited from withholding information due to political sensitivity or reputational harm. Additionally, the bill mandates economic analysis of these agreements by the CBO and GAO.
Yes· 3 of 10
- Scored +8
Does this make what the government does easier for the public to see?
The bill requires the public release of records, communications, and contracts related to private drug pricing deals.
- Scored +5
Does this lower the price of prescription medicines?
The bill increases transparency regarding pricing deals that include reduced drug prices and direct-to-consumer sales.
- Scored +4
Would people over 65 be better off under this?
Increased transparency in drug pricing agreements may help lower costs for those on Medicare.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Increased Transparency of Drug Pricing: The Secretary must make available all records, documents, communications, and contracts relating to various pricing agreements in a searchable and downloadable format (Section 2(a)(1)).
-
Economic and Budgetary Oversight: The Congressional Budget Office and the Comptroller General are required to publish a report detailing the economic effects of these agreements, including expected direct cost savings for individuals in the United States based on their insurance status (Section 4).
-
Program Impact Analysis: The bill requires a budget analysis regarding the impacts of these agreements on Medicare, Medicaid, and qualified health plans (Section 4(3)).
-
Monitoring Competition and Costs: The required reporting includes an analysis of the impact on drug price competition and health plan formulary design (Section 4(4)).
Potential Negative Impacts for People
-
Redaction of Proprietary Information: The Secretary may withhold or redact specific portions of agreements that contain proprietary pricing information or information protected by other laws (Section 2(c)).
-
Limited Information Access: The Secretary may withhold information that manufacturers are legally prohibited from disclosing based on the laws of other nations or as part of specific settlements or court directives (Section 2(c)).
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Demographic And Interest Groups
- Would households on low incomes be better off under this? — The bill requires tracking of direct cost savings for individuals, including the uninsured. Would people over 65 be better off under this? — Increased transparency in drug pricing agreements may help lower costs for those on Medicare. Would middle-income households be better off under this? — Enhanced oversight of drug pricing agreements aims to identify and implement cost-saving measures for consumers.
- Healthcare
- Does this lower the price of prescription medicines? — The bill increases transparency regarding pricing deals that include reduced drug prices and direct-to-consumer sales. Does this put more money into Medicaid, the health coverage for people on low incomes? — The bill requires a budget analysis of how drug pricing agreements impact the Medicaid program. Does this put more money into Medicare, the health coverage for people over 65? — The bill requires a budget analysis of how drug pricing agreements impact the Medicare program.
- Governance And Ideology
- Does this make what the government does easier for the public to see? — The bill requires the public release of records, communications, and contracts related to private drug pricing deals.
- Economy And Finance
- Does this make the government pay for what it commits to? — The bill mandates economic and budgetary analysis of drug pricing agreements by the CBO and GAO to monitor fiscal impacts.
- Social Issues And Justice
- Is this likely to lift people out of poverty? — By analyzing direct cost savings for individuals, the bill aims to address the economic burden of drug costs.
- National Security And Foreign Policy
- Does this increase the pay, pensions or support veterans receive? — The bill monitors agreements that could affect the cost of drugs, which impacts healthcare accessibility for veterans.
- 4/27/2026
- 1 Cosponsor added.
- 4/21/2026
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 17 Cosponsors added.
- Introduced in Senate
One bill Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Tammy BaldwinDemocrat · Wisconsin
Michael BennetDemocrat · Colorado
Maria CantwellDemocrat · Washington
Catherine Cortez MastoDemocrat · Nevada
Ruben GallegoDemocrat · Arizona
Mazie HironoDemocrat · Hawaii
Maggie HassanDemocrat · New Hampshire
Mark KellyDemocrat · Arizona
Ben LujánDemocrat · New Mexico
Jeff MerkleyDemocrat · Oregon
Bernie SandersIndependent · Vermont
Tina SmithDemocrat · Minnesota
Chris Van HollenDemocrat · Maryland
Raphael WarnockDemocrat · Georgia
Peter WelchDemocrat · Vermont
Sheldon WhitehouseDemocrat · Rhode Island
Mark WarnerDemocrat · Virginia
Elizabeth WarrenDemocrat · Massachusetts